Effects of Repeated Transcranial Magnetic Stimulation (rTMS) on the Treatment of Cocaine Addicted Patients
NCT ID: NCT01259362
Last Updated: 2010-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
40 participants
INTERVENTIONAL
2010-03-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to evaluate reduction if craving and other parameters related to addiction within this group of patients through a treatment with transcranial magnetic stimulation.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After the rTMS they are going to be offered cognitive therapy to prevent relapse.
The area stimulated is the dorso-lateral prefrontal cortex. This technique was employed in previous studies and the risks are insignificant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcranial Magnetic Stimulation
Cocaine addicted will receive a 20 day TMSr to right dorsolateral prefrontal cortex.
Transcranial Magnetic Stimulation
5 Hz, 120 % motor threshold, intertrain interval 20s, number of pulses in train 50.
Transcranial Magnetic Stimlation
cocaine addicted will receive a 20 day sham TMSr to right dorsolateral prefrontal cortex
Transcranial Magnetic Stimulation
Cocaine addicted will receive 20 sham TMSr
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Magnetic Stimulation
5 Hz, 120 % motor threshold, intertrain interval 20s, number of pulses in train 50.
Transcranial Magnetic Stimulation
Cocaine addicted will receive 20 sham TMSr
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Maximum age of 40
* Diagnostic of Cocaine addiction
* Willingly participate the study
Exclusion Criteria
* History of Severe Brain trauma or injury
* Organic Brain Disease
* Severe Somatic Disease
* History of other actual or past psychiatric diagnostics
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department and Institute of Psychiatry, General Hospital University of Sao Paulo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip L Ribeiro, MD
Role: PRINCIPAL_INVESTIGATOR
Post Graduate Student Department of Brain Stimulation - IPQ - HC FMUSP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department and Institute of Psychiatry, General Hospital, University of Sao Paulo medical school
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Philip L Ribeiro, md
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PLRIBEIRO1
Identifier Type: -
Identifier Source: org_study_id